entertainment -WSS

entertainment

author：fashion 2025-09-03 15:19:33 - browse：79

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Doctors push to include dialysis machines in emergency stockpile

entertainment

WSS

It was time to plan for my old age. If only I could stop crying

NFL doctors' conflicts of interest could endanger players, report says

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Fetal surgery at risk from Dobbs and new abortion restrictions

Judge in Trump's classified documents case questions use of out

hotspot

entertainment

hotspot

Medical leaders decry Supreme Court decision on affirmative action

What don’t we know about an Alzheimer’s drug side effect?

Malaria cases in Florida and Texas: Here’s what you need to know

The EPA's new lead rule: How one expert crunched the numbers

Bright Health sells Medicare Advantage business to Molina

Flash flood warnings continue for parts of Missouri, Illinois

Hollywood unions extend contract negotiations for actors

Judge in Trump's classified documents case questions use of out

Drug repurposing or repositioning? The language matters

As biotech industry slumps, bioscience job market is upside down

Wikipedia

With heat waves through August, officials warn of health risks

It was time to plan for my old age. If only I could stop crying

NFL doctors' conflicts of interest could endanger players, report says

Feed a cold, starve a fever? Here’s what science says

Flash flood warnings continue for parts of Missouri, Illinois

The EPA's new lead rule: How one expert crunched the numbers

leisure time

entertainment

Wikipedia

knowledge